PAR paradigm biopharmaceuticals limited..

12.1%

32.5¢

Where are we on a deal?, page-23

First 23 Last

Share
Profile

Follow
asx11

5,000 Posts.

532

15/10/24

18:48

Post #: 76135057
Share

Originally posted by Dungiven: ↑

Just a couple more verbatims from Paul relating to partnering:

"Our preference would be to have a co-funding partner, so a pharmaceutical company. We are in discussions with a number of companies. We have discussed with those companies the possibility of them assisting with the funding. They may fund the bulk of that, or they may fund a component of that and then the remainder come from other partnering deals that we might have in regional areas such as China or South America, and that money contributes to a total pot of being able to fund it via partnerships, as opposed to going back to investors and offering them equity. Given the low share price, our preference is not to go back to the market, but we have to do what we have to do to get the money to keep the program running."

- Paul Rennie to Alan Kohler July 2024

"As Beverly said [in her AGM presentation], we are very confident that we will bring a deal home by June 2024. And i'm sure if we don't there'll be plenty of people in the audience who'll remind me at the next AGM. So, the pressure is on. We understand that, but we want a deal more than you can imagine, more that what investors want, we want to be able to get commercial companies seeing exactly what we're seeing in terms of the tremendous value that this brings to the market of treating osteoarthritis."

- AGM, November 2023

They clearly felt confident at the end of 2023 that they'd get FDA clearance in early 2024 and have a deal signed by EOFY24. They were overly-optimistic on the timelines for that FDA clearance. Almost a year later we have only just received feedback/guidance from the Agency to inform the submission of the revised protocol. The good news, is that the feedback was positive and appears highly acceptable to the company, and highly workable. The full clearance in now potentially only weeks away, with a 30 day nervous wait after submission, which could be any day now, or could take weeks more (we don't really know). The FDA will do what they do, and it's nobody elses fault but PARs for giving the market such optimistic guidance which they ultimately could not meet - but nonetheless, the bullishness of the language around confidence in a deal still encourages. And as harsh as I like to be on PAR management (given the errors of the past) I do appreciate that not having FDA clearance yet is a reasonable cause for subsequently missing that timeline. I don't see any reason why that bullishness is not all still there, and ready to return with vigour, once the green light eventually comes (which i'm confident it will).

Expand

"Given the low share price, our preference is not to go back to the market, but we have to do what we have to do to get the money to keep the program running"

Last edited by asx11: 15/10/24

PAR Price at posting: 20.0¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

MTS

'Outperforming' Metcash books profits lift – even as illegal tobacco rocks sales

Virgin joins Greatland, VBX Ltd as IPO market heats up ahead of FY26

SPN

Sparc opens small-scale green H2 plant in SA, but liquidity dried up

ASX Market Close: Virgin soars on IPO | June 24, 2025

There are more pages in this discussion • 120 more messages in this thread...

First 23 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 32.5¢		Change 0.035(12.1%)		Mkt cap ! $126.5M

Open	High	Low	Value	Volume
29.0¢	33.5¢	29.0¢	$692.3K	2.176M

Buyers (Bids)

No.	Vol.	Price($)
1	11161	32.5¢

Sellers (Offers)

Price($)	Vol.	No.
33.0¢	134295	1

View Market Depth

No.	Vol.	Price($)
1	11161	0.325
2	98935	0.320
1	16393	0.315
1	100000	0.310
1	50000	0.305

Price($)	Vol.	No.
0.330	134295	1
0.335	19000	2
0.340	63000	2
0.345	12500	3
0.350	86642	5

Last trade - 16.10pm 24/06/2025 (20 minute delay)

PAR (ASX) Chart

Where are we on a deal?, page-23

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

'Outperforming' Metcash books profits lift – even as illegal tobacco rocks sales

Virgin joins Greatland, VBX Ltd as IPO market heats up ahead of FY26

Sparc opens small-scale green H2 plant in SA, but liquidity dried up

ASX Market Close: Virgin soars on IPO | June 24, 2025

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Where are we on a deal?, page-23

Top Stories

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

'Outperforming' Metcash books profits lift – even as illegal tobacco rocks sales

Virgin joins Greatland, VBX Ltd as IPO market heats up ahead of FY26

Sparc opens small-scale green H2 plant in SA, but liquidity dried up

ASX Market Close: Virgin soars on IPO | June 24, 2025

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News